Press Release Exelixis’ Partner Ipsen Receives European Commission Approval for CABOMETYX® (cabozantinib) for Patients with Previously Treated Advanced Neuroendocrine Tumors 24 July 2025
Press Release Incyte To Present Initial Data for its TGFβR2×PD-1-directed Bispecific Antibody (INCA33890) and its Selective Inhibitor of G12D-mutated KRAS (INCB161734) at the European Society of Medical Oncology (ESMO) Congress 2025 24 July 2025
Press Release DNIB.com Reports Internet Has 371.7 Million Domain Name Registrations at the End of the Second Quarter of 2025 24 July 2025
Press Release Hamilton ETFs Announces July 2025 Monthly & Upcoming Semi-Monthly Cash Distributions 24 July 2025
